|
| Press Releases |
|
 |
|
| Thursday, July 28, 2022 |
|
|
Led by Legend Capital, The Leading Intelligent Special Robot Company AKA Robotics Completes Series A Financing |
| Shenzhen AKA Robotics Technology Co., LTD. (hereinafter referred to as "AKA Robotics"), a leading intelligent special robot company, recently completed its Series A financing round, which was led by Legend Capital. more info >> |
|
| Thursday, July 21, 2022 |
|
|
Legend Capital Portfolio Company: The Global-Leading AI Medical Imaging Company Lunit Goes Public Successfully |
| On July 21st, 2022, Lunit, a leading global AI-based cancer solutions provider invested by Legend Capital, was successfully listed on the KOSDAQ market. more info >> |
|
| Thursday, July 7, 2022 |
|
|
Co-led by Legend Capital, Huili Biotechnology Completes Series A Financing Round with Hundreds of Million RMB |
| Jiangsu Huili Biotechnology Co., Ltd ("Huili Bio"), a next-generation synthetic biology enzyme computational design platform, recently announced the completion of its Series A financing round with hundreds of million RMB. more info >> |
|
| Thursday, June 16, 2022 |
|
|
Legend Capital Increases Carbon Neutrality Investments: Portfolio Company Talent New Energy Completes A++ Financing Round with Several Hundred Million RMB |
| Legend Capital's portfolio company Talent New Energy, a new Chinese powerhouse in the solid-state battery industry, recently announced the completion of its Series A++ financing round with several hundred million RMB. more info >> |
|
| Wednesday, June 15, 2022 |
|
|
Breakthrough Cooperation of Legend Capital's Cross-border Portfolio Companies: Innovent and Etana Jointly Announce the Approval of Bevagen by the BPOM |
| On June 14, two of Legend Capital's portfolio companies, Innovent Biologics, Inc. ("Innovent") and PT Etana Biotechnologies Indonesia ("Etana"), jointly announced that the Indonesian Food and Drugs Authority (BPOM) had approved Bevagen (bevacizumab biosimilar) more info >> |
|
| Thursday, June 9, 2022 |
|
|
Legend Capital Portfolio: Japan's No.1 VTuber Operator ANYCOLOR Lists on the Tokyo Stock Exchange |
| On June 8th 2022, Legend Capital's portfolio company ANYCOLOR, a leading Virtual YouTuber (VTuber) management company in Japan, was listed on the Tokyo Stock Exchange. more info >> |
|
| Friday, May 27, 2022 |
|
|
Legend Capital's Portfolio Company Feima Robotics Assists China's 38th Antarctic Expedition with a Series of Civilian UAV Products |
| On April 26, 2022, the expedition ship Xuelong 2 for China's 38th Antarctic expedition berthed at the Shanghai base dock. So far, China's 38th Antarctic expedition, which lasted 174 days and traveled more than 33,000 nautical miles, has ended successfully. more info >> |
|
| Wednesday, April 27, 2022 |
|
|
Legend Capital's Portfolio Company Xbiome Acquires Clinical-Stage Program Targeting Ulcerative Colitis |
| Legend Capital's portfolio company Xbiome Inc., an industry-leading and AI-driven microbiome therapeutics company, recently announced that it acquired the clinical-stage M201 program from Assembly Biosciences, Inc., a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus and other viral diseases. more info >> |
|
| Tuesday, April 26, 2022 |
|
|
Legend Capital Portfolio: Korean Medical AI Company Lunit to List on KOSDAQ in 2Q2022 |
| Legend Capital's portfolio company Lunit, a Korean Medical AI company, recently announced a preliminary approval from the Korea Exchange for initial public offering (IPO) on the KOSDAQ market, and it plans to submit a registration statement within the second quarter of 2022. more info >> |
|
| Sunday, April 24, 2022 |
|
|
Legend Capital's Co-founded Company Innostellar Biotherapeutics: IRD Gene Therapy Product was Approved for Clinical Trial in China |
| Shanghai Langsheng Biotechnology Co., Ltd., a subsidiary of Legend Capital's co-founded company Innostellar Biotherapeutics more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Avenix Fzco Introduces Avexbot: Data-Driven Precision for Forex Traders
Apr 2, 2025 08:00 HKT/SGT
|
|
|
Euro Manganese Announces Upsize to Previously Announced Financing of up to C$11.2m (A$12.3m) including a Private Placement with Eric Sprott
Apr 1, 2025 22:39 HKT/SGT
|
|
|
Wuling Motors (00305.HK) Achieves a Surge of 115.6% in Net Profit Attributable to Shareholders for 2024
Apr 1, 2025 21:53 HKT/SGT
|
|
|
Baguio Green Group Announces 2024 Annual Results
Apr 1, 2025 20:19 HKT/SGT
|
|
|
analytica Vietnam 2025 Opens Tomorrow: The Leading Laboratory Exhibition Returns to Vietnam
Apr 1, 2025 20:01 HKT/SGT
|
|
|
Sunshine Insurance: Practicing 'Insurance for the People'
Apr 1, 2025 18:50 HKT/SGT
|
|
|
Hitachi's New Corporate Vision: Changing the World and Future with the Power of Knowledge
Apr 1, 2025 18:46 JST
|
|
|
Hitachi: Strengthening Our Analytical Business to Solve Social Issues with Our Core Technologies
Apr 1, 2025 18:38 JST
|
|
|
Quam Greater China Magnificent 7 Makes a Stunning Debut: Don't Miss the Next Wave of China Investment Opportunities
Apr 1, 2025 17:27 HKT/SGT
|
|
|
Hitachi: Completion of New Production Facility for Semiconductor Manufacturing Equipment in Kasado Area
Apr 1, 2025 17:52 JST
|
|
|
FOURTH PARADIGM ANNOUNCES 2024 ANNUAL RESULTS
Apr 1, 2025 16:51 HKT/SGT
|
|
|
NEC has developed technologies that enable a secure workflow for personalized cancer vaccines and has proven their capabilities
Apr 1, 2025 16:15 JST
|
|
|
Mitsubishi Motors Launches Miland Virtual Car Lifestyle App Service
Apr 1, 2025 14:59 JST
|
|
|
Mitsubishi Corporation: Development of R&D Hub "iPark Kobe" in Kobe Medical Industry City
Apr 1, 2025 14:16 JST
|
|
|
Eisai to Divest Rights for Pariet in China to Peak Pharma
Apr 1, 2025 13:15 JST
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
